Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Neoplasms × Albumin-Bound Paclitaxel × Clear all

Phase

Status

Sponsor Class

INDUSTRY 15 OTHER 13 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 4 Neoplasm Metastasis 2 Uterine Cervical Neoplasms 1 Radiation Injuries 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Surveys and Questionnaires 2 Proton Therapy 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Busulfan 2 tremelimumab 1 motesanib diphosphate 1 luprolide acetate gel depot 1 liposomal amphotericin B 1 durvalumab 1 copanlisib 1 chlorhexidine gluconate 1 batifiban 1 Whole Genome Sequencing 1 Watchful Waiting 1 Thrombopoietin 1 Taxes 1 Spermine Synthase 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Psychiatrists 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01746225 2023-06-01

SNAP

ETOP IBCSG Partners Foundation

Phase 2 Completed

258 enrolled 17 charts

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡